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Cancer is one of the significant health problems in 
developed and developing countries. It is the second 
leading cause of death globally1. Unfortunately, despite 
their structural diversity, most currently approved 
anticancer drugs have drawbacks, mainly due to their 
harmful effects extended to normal cells, with further 
consequences on health2. Up to date, secondary 
metabolites continued to be a potential source of 
anticancer leads and utilized as a source of many 
therapeutic and preventive anticancer agents. 
Interestingly, more than 60 % of currently used 
anticancer drugs are derived from natural sources3. 
Haplophyllum tuberculatum (Forsk.) of the Rutaceae family 
is used in folk medicine for malaria and parasitic 
infections4. Moreover, H. tuberculatum is used for many 
digestive, gynecological, respiratory, cardiovascular, and 
CNS disorders5,6. A literature survey showed that H. 
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This study aimed to investigate the anticancer activity of Haplophyllum 
tuberculatum (Forsk.) aerial parts ethanol extract and fractions and 
reveal the potential anticancer targets, binding modes, 
pharmacokinetics, and toxicity properties of its 
phytoconstituents. MTT assay was used to investigate the anticancer 
activity. TargetNet, ChemProt version 2.0, and CLC-Pred web servers 
were used for virtual screening, and Cresset Flare software was used 
for molecular docking with the 26 predicted targets. Moreover, 
pkCSM, swiss ADME, and eMolTox web servers were used to predict 
pharmacokinetics and safety. Ethanolic extracts of H. tuberculatum on 
HepG2 and HeLa cell lines showed promising activities with IC50 
values 54.12 and 48.1 µg/mL, respectively. Further, ethyl acetate 
fraction showed the highest cytotoxicity on HepG2 and HeLa cell lines 
with IC50 values 41.7 and 52.31 µg/mL. Of 70 compounds screened 
virtually, polygamain, justicidin A, justicidin B, haplotubine, 
kusunokinin, and flindersine were predicted as safe anticancer drugs 
candidates. They showed the highest binding scores with targets 
involved in cell growth, proliferation, survival, migration, tumor 
suppression, induction of apoptosis, metastasis, and drug resistance. 
Our findings revealed the potency of H. tuberculatum as a source of 
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tuberculatum contains more than 50 phytoconstituents, 
including polyphenols, alkaloids, lignans, flavonoids, 
and essential oils6-10. Therefore, it is necessary to conduct 
research to investigate the biological activity, safety, and 
determination of the appropriate biological target of the 
phytochemical constituents of H. tuberculatum.   
Although identifying drug targets is an essential step in 
understanding the mechanism of action, it is a 
challenging task mainly because of its complexity. 
Therefore, there is a need to use advanced technologies 
such as computer-aided drug design tools, including 
virtual screening molecular docking, to identify drug 
targets.11,12. With this background information, this study 
aims to investigate the anticancer effect of H. tuberculatum 
aerial parts ethanol extract and fractions on HeLa 
(cervical) and HepG2 (liver) cell lines, as well as to reveal 
the potential anticancer targets, binding modes, 
pharmacokinetics, and toxicity properties of reported 
phytoconstituents using virtual computational methods. 
 
MATERIALS AND METHODS 
Materials 
Aerial parts (stem, leaves, flowers, fruits) of H. 
tuberculatum were collected from the Southern region of 
Saudi Arabia. The plant material was authenticated by 
Dr. Mohammed Yusuf, a taxonomist at the Department 
of Pharmacognosy, College of Pharmacy, King Saud 
University, with a voucher specimen (No. 16324) was 
deposited. Human cancer cell lines HeLa and HepG2 
were grown ingrown in T 75 culture flasks (Corning, US) 
at 37⁰C in a humified incubator with 5% CO2 supply.  The 
basic culture medium, DMEM (Invitrogen, US), was 
supplemented with 10% heat-inactivated bovine serum 




Preparation of ethanol extract and fractions 
Dried powdered plant materials (60 g) were soaked in 
80% ethanol (Merck, Germany) for three days at 25-30°C 
and then filtered. Extraction was repeated twice, as 
described previously. The extract was collected through 
Whatman filter paper No.1, and then evaporated using a 
rotary evaporator (Buchi, Switzerland) under reduced 
pressure at 40°C. The obtained semi-solid extract (5.79 g) 
was suspended in distilled water and then fractionated 
three times successively with the same volume of hexane 
(Merck, Germany), dichloromethane (Merck, Germany), 
ethyl acetate (Merck, Germany), and aqueous saturated 
n-butanol (Loba Chemie, India) to provide the 
corresponding fractions. Then, organic solvents were 
evaporated at reduced pressure using a rotatory 
evaporator. After drying, ethanol extract and fractions 
were stored at -20°C until subsequent use for screening. 
In vitro cytotoxicity assay 
Ethanolic extract, as well as fractions of H. tuberculatum, 
were tested for cytotoxic activity using a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) cell proliferation assay using TACS MTT Cell 
Proliferation Assay kit (Tervigen, US). The MTT assay 
was based on the metabolic reduction of soluble MTT by 
mitochondrial enzyme activity of viable cells into an 
insoluble colored formazan product which can be 
solubilized and measured optically13. Cells were seeded 
in flat-bottom 96 well plates (0.5×105 cells/well) and 
grown for 20 hours. Haplophyllum tuberculatum extract 
and organic fractions were dissolved in dimethyl 
sulphoxide (DMSO; 100 mg/mL), then diluted in culture 
media to prepare five doses (0, 12.5, 25, 50, and 100 
µg/mL) of each. The final concentration of DMSO used 
was less than 0.1%, thus had no toxicity, and cells were 
treated in triplicate/dose and incubated. Untreated cells 
(0.1% DMSO in media) and blank (only media) controls 
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were also included. After 48 hours post-treatment, cells 
were treated with MTT reagent (10 µL/well) and 
incubated at 37°C for 4 hours. Upon the appearance of a 
purple color, the detergent solution (100 µL) was added 
to each well and further incubated at 37°C for an hour. 
Optical density (OD) was recorded at 570 nm using a 
microplate reader ELx800 and cell survival fraction was 




 × 100 … [1] 
In which ODs, ODb, and ODc were the optical density of 
the sample, blank and negative control, respectively14. 
Data were subjected to analysis using Microsoft Excel 
software, and the survival fraction was plotted against 
the concentration. The concentration required for 50% 
inhibition of cell viability (IC50) was calculated. The 
extracts that fail to inhibit 50% of cell viability up to 100 
µg/mL were considered inactive. 
In silico cytotoxicity and drug-likeness prediction 
The cytotoxic effect of about 70 compounds reported H. 
tuberculatum phytochemical constituents6-10 were 
predicted using Cell Line Cytotoxicity Predictor (CLC-
Pred)15. The probability of phytochemical constituents to 
be a drug candidate was predicted using the 
SwissADME webserver16. 
Virtual screening and molecular docking 
Virtual screening for anticancer targets depended on a 
protocol described by Al-Nour et al.12 with a modification. 
The chemical structures of reported H. tuberculatum 
phytochemical constituents were sketched by Marven 
Sketch software version 18.5 and saved as a mol. file 
format. The 3D structures were generated and optimized 
accurately using Cresset Flare software17. The virtual 
screening for anticancer targets was conducted by 
submitting the structures to TargetNet18, ChemProt 
version 2.019, and CLC-Pred20 web servers in SMILES 
format. The predicted targets were for further validation 
via molecular docking. The 3D structures of the predicted 
targets were downloaded from the RCSB protein data 
bank21, prepared for docking, and minimized via Cresset 
Flare software17. For the validation, two 3D structures 
with different PDB IDs were downloaded.  
The molecular docking calculations were conducted 
using Cresset Flare software17 at the normal mode and 
default setting. The co-crystallized ligands were used to 
determine the grid box; however, in the absence of a co-
crystallized ligand, the grid box was determined by 
selecting the active site amino acids. The co-crystallized 
ligands and the known target’s ligands were used as 
positive controls. 
Pharmacokinetics and toxicity prediction 
The pkCSM22 and SwissADME16 web servers were used 
to predict intestinal absorption, the apparent volume of 
distribution, clearance, and CYP-450 enzyme inhibition. 
Furthermore, the pkCSM22 and eMolTox20 web servers 
were used to predict the toxicity of phytochemical 
constituents on major organs (cardiotoxicity, 
hepatotoxicity, and renal toxicity). 
 
RESULTS AND DISCUSSION 
In vitro cytotoxicity assay 
The in vitro cytotoxic activity of H. tuberculatum ethanol 
extract and fractions was evaluated against HeLa and 
HepG2 cancer cell lines. The IC50 was calculated by 
plotting the survival fraction against concentration, as 
shown in Figure 1. Haplophyllum tuberculatum ethanol 
extract showed cytotoxic activity against HeLa and 
HepG2 with IC50 values of 54.12 and 48.1 µg/mL, 
respectively. In comparison, the IC50 values for hexane, 
chloroform, and ethyl acetate fractions against HeLa cells 
were 61.12, 79.4, and 52.31 µg/mL, respectively. Only 
hexane and ethyl acetate fractions showed activity 
against HepG2 cells with IC50 values of 75.6 and 41.7 
µg/mL, respectively. 
Al-Nour MY, Arbab AH, Parvez MK, Mohamed AY, Al-Dosari MS. 2021. Cytotoxicity and Anticancer from Haplophyllum tuberculatum 
195 
 
Figure 1. In vitro cytotoxic activity of the H. tuberculatum 
ethanol extract and fractions against HeLa and HepG2 cell 
lines by MTT assay; IC50, half-maximal inhibitory 
concentration; EtOH: ethanol extract, Hex: hexane fraction, 
Chl: chloroform fraction, EtAc: ethyl acetate fraction 
 
These findings revealed that the crude ethanol extract 
exhibited marked inhibition in both HeLa and HepG2 
lines in a dose-dependent manner with IC50 values of 
54.12 and 48.1 µg/mL, respectively. Therefore, it was 
subjected to sequential fractionation and subsequent 
screening. The highest anticancer activity was associated 
with the ethyl acetate fraction, followed by the hexane 
fraction (Figure 1). Notably, the variable activities shown 
by the different fractions might be attributed to the 
diversity of structure and/or uneven distribution of 
phytochemical constituents present in these fractions. 
Nevertheless, this further suggests that the bioactive 
compounds were of low to intermediate polarity. 
Virtual screening and molecular docking 
Once the biological activity was confirmed, identifying 
the drug target was a valuable subsequent step that leads 
to further success in the drug development pipeline11.  It 
was challenging work; hence, it requires sophisticated 
tools to reduce the difficulty12. Recently, the use of 
computer-aided drug design tools leads to the successful 
prediction of many drug targets. Several studies reported 
the involvement of computational tools in discovering 
natural drugs23-26. Consequently, in this study, virtual 
screening and molecular docking were used to predict 
the targets that phytochemical constituents exert their 
cytotoxicity through. 
Initially, the cytotoxicity and the drug-likeness 
probability of known phytoconstituents of H. 
tuberculatum were predicted. Out of the 70 screened 
compounds, 47 were predicted as cytotoxic drug 
candidates. Their probable targets were predicted, and 
their interactions were studied using the molecular 
docking technique. The promised compounds with their 
target were listed in Table I.  
According to the virtual screening and molecular 
docking, the cytotoxic effect of H. tuberculatum was due to 
the interaction with vital targets that were involved in cell 
growth, proliferation, and survival, migration, tumor 
suppression, induction of apoptosis, resistance to 
apoptosis, metastasis, as well as drug resistance. Table I 
shows polygamain, justicidin A, justicidin B, γ-fagarine, 
skimmianine, haplotubine, kusunokinin, and flindersine 
were the phytochemical constituents that contribute to 
the cytotoxicity of H. tuberculatum. 
Virtual screening was based on strictly evaluated and 
validated QSAR models18. Besides, the molecular 
docking study was performed using Cresset Flare 
software characterized by well-respected accuracy and 
efficiency17,26. The predicted cytotoxicity was due to the 
inhibition of tumor cells growth, proliferation, and 
survival via the interaction with Dual specificity protein 
kinase CLK1, Dual specificity tyrosine-phosphorylation-
regulated kinase 1A, topoisomerase II enzyme, 
transcription factor p65, peroxisome proliferator-
activated receptor-γ, mitogen-activated protein kinase 14, 
thyrotropin receptor, and phosphatidylinositol-4 5-
bisphosphate 3-kinase catalytic subunit α. Besides, the 
predicted cytotoxicity was due to tumor suppression via 
the interaction with Cellular Tumor antigen p53, Menin, 
Runt-related transcription factor 1, and Serine-protein 
kinase ATM, as well as the inhibition of tumor cells 
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migration via the interaction with Tubulin β-2B chain, 
Receptor-interacting serine/threonine-protein kinase 2, 
and Protein kinase C αtype. Furthermore, the predicted 
cytotoxicity was due to the induction of apoptosis via the 
interaction with Caspase 3 and 8 enzymes tumor necrosis 
factor receptor superfamily member 6, the inhibition of 
anti-apoptotic protein Bcl-2 and BAX, as well as the 
inhibition of drug resistance via the interaction with 
multidrug resistance protein 1 and 2. 
Table I. Molecular docking results of the H. tuberculatum 
phytochemical constituents with their predicted 
targets 
Target Compounds Docking score 
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Note: The bolded code was the target 3D structure were the PDB IDs. The italic 
compounds were the co-crystallized ligands. The bolded compounds were positive 
controls 
 
Al-Nour MY, Arbab AH, Parvez MK, Mohamed AY, Al-Dosari MS. 2021. Cytotoxicity and Anticancer from Haplophyllum tuberculatum 
197 
According to molecular docking, the lowest energy score 
indicates the highest binding affinity27. Hence, 
polygamain, justicidin A, justicidin B, haplotubine, 
kusunokinin, and flindersine were the compounds with 
the highest binding affinity. The 3D interaction of the 
best-predicted compounds shows a ligand 
superimposing between the best-predicted compounds 
and the controls. However, polygamain binds at a 
different position on the active site of the multidrug 
resistance protein 1 from the co-crystallized ligand A 
CLR 1306, as shown in Figure 2. Polygamain has the 
highest binding affinity to the vast majority of the 
predicted targets among the best-predicted compounds. 
Due to the vast number of predicted targets, a 
representative example was given to illustrate the 3D and 
2D interactions. The results showed that polygamain 
interacts with the Dual specificity tyrosine-
phosphorylation-regulated kinase 1A and Cellular 
Tumor antigen p53 in the same binding sites of their co-
crystallized ligands. It binds with the exact position of A 
B5Z 501 and a different position from A EY2 401. In 
contrast, justicidin A binds in a position similar to D SA3 
990, as shown in Figure 2.   
In comparison between interactions of polygamain, 
justicidin A, and the co-crystallized ligands, A B5Z 501 
forms additional hydrogen bond with the dual specificity 
tyrosine-phosphorylation-regulated kinase 1A binding 
site making its virtual screening score (-10.072) better than 
polygamain (-8.966). The A EY2 401 forms six 
hydrophobic bonds with the binding sites of the Cellular 
Tumor antigen p53, much than polygamain (three 
bonds). However, the amino acids clashes made its 
virtual screening score (-8.323) lower than polygamain (-
8.885). In contrast, the atom clashes and fewer bonds in 
the interaction of justicidin A with the topoisomerase I 
enzyme made its virtual screening score (-10.893) lower 










Figure 2. The 3D interaction between the best predicted H. 
tuberculatum phytochemical constituents with their predicted 
targets. A: Polygamain (dark yellow) and A B5Z 501 
(turquoise) with dual-specificity tyrosine phosphorylation-
regulated kinase 1A. B: Polygamain (dark yellow) and A EY2 
401 (turquoise) with Cellular Tumor antigen p53. C: Justicidin 
A (violet) and D SA3 990 (turquoise) with Topoisomerase I 
enzyme. 
 








Figure 3. The 2D interaction between the best predicted H. tuberculatum phytochemical constituents with their predicted targets. A: 
Polygamain (left) and A B5Z 501 (right) with dual-specificity tyrosine phosphorylation-regulated kinase 1A. B: Polygamain (left) and A 
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Pharmacokinetics and toxicity prediction 
Web servers were used to predict the promised 
anticancer phytochemical constituents of H. tuberculatum 
compounds' toxicity, and results are summarized in 
Table II. Polygamain, skimmianine, kusunokinin, and 
flindersine had the best pharmacokinetics and safety 
profile among those compounds. Moreover, the 
pharmacokinetics and toxicity prediction results of 
polygamain showed that it had the highest absorption 
(100%), was permeable to the blood-brain-barrier BBB, 
and was free from significant organ toxicity 
(cardiotoxicity hepatotoxicity, nephrotoxicity, and CNS 
toxicity). Consequently, polygamain would be a 
promising drug-like compound for the treatment of 
many types of cancers. 
Table II. Pharmacokinetics and toxicity prediction of the 






































































Yes -0.198 0.744 CYP1A2 No 
Skimmianine High 
(97.967) 
Yes 0.046 0.757 CYP3A4, 
CYP1A2 
No 
Kusunokinin High  
(97.192) 




Flindersine High  
(95.319) 
Yes 0.543 0.196 CYP1A2 No 
*Blood brain barrier permeability, **Volume of distribution (-log/Kg), 
***Clearance (log mL/min/kg) 
 
In agreement, polygamain from Amyris madrensis was 
found to has a cytotoxic effect against human PC3 cells28. 
Justicidin B was found to had a potent cytotoxic and pro-
apoptotic effect on human breast cancer-derived cell 
lines29 and acute myeloid leukemia-derived cell line HL-
6030. Though the effectiveness of using virtual screening 
and molecular docking for drug targets prediction12,17,18, 
experimental studies were recommended to validate the 
predicted targets to develop strong evidence regarding 
the role of the predicted target in the cytotoxicity of H. 
tuberculatum phytochemical constituents. Moreover, 
RMSD calculations and molecular dynamics simulation 
are recommended to validate docking calculations. 
 
CONCLUSION 
Our findings concluded that H. tuberculatum has 
anticancer potential. Polygamain, justicidin A, justicidin 
B, γ-fagarine, skimmianine, haplotubine, kusunokinin, 
and flindersine were the phytochemical constituents that 
contribute to the cytotoxicity of H. tuberculatum. They 
exert their cytotoxic effect via the interaction with vital 
targets involved in cell growth, proliferation, and 
survival, migration, tumor suppression, induction of 
apoptosis, resistance to apoptosis, metastasis, as well as 
drug resistance. However, further phytochemical and 
biological studies are required to isolate the active 
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